The protocol of an ongoing international controlled clinical trial advises using the oscillometric method with an automated and validated device for blood pressure measurement wherever mercury manometers are forbidden by local regulations. Validation procedures, eg edited by AAMI 1 or by CE 2 , ensure that on average the systolic and diastolic differences between the two methods do not exceed 5 ± 8 mm Hg. In the British Hypertension Society (BHS) 3 protocol the standard deviation is usually smaller but may also be higher if the mean error is close to zero. An instrument passes this procedure if 50% of the differences are smaller than 5 mm Hg, 75% smaller than 10 mm Hg and 90% smaller than 15 mm Hg. Some further limitations must be kept in mind. Although the different protocols to date are based on more than 80 test persons, there may be insufficient representation of persons with very high or very low blood pressure values. As the bulk of test persons are 40 to 60 years old, the results may not be representative for younger and elderly patients. Finally, test devices are usually not taken from the market. Usually prototypes which are carefully checked are sent to the testing institutes by the producer. In most countries continuous market surveillance is limited to the pneumatic part of the instruments and not extended to other systems, eg to signal processing, crucial for the results of blood pressure measurements. Some lessons can be learned from the HOT study. 4 In June 1998, the principle results of the study were published. The paper includes the statement that the oscillometric semiautomatic device Visomat OZ, D2 used in the study 'was found to meet those stringent criteria' of the BHS testing protocol. More than 2 months later we learned from the published data 5 of the test comparing Visomat to Korotkoff measurements that it does not.
On average the systolic blood pressure measured by the Visomat device is 6.4 mm Hg lower than values taken by the standard method of Riva-Rocci and Korotkoff. The further evaluation of the systolic differences given in the publication would only permit a grade of C, whereas only grades A and B meet the BHS criteria. This poor result was achieved although the authors used means of 'cases' instead of single 'readings' for calculation.
The results for the diastolic blood pressure are also questionable. Though not claimed, the presentation of data suggests a grade of A according to BHS. But as with the systolic values, the scatter of differences of comparative measurements has been reduced by taking the mean of four comparative measurements in each patient. Consequently the means of 'cases' give better results than single 'readings', but 'readings' are demanded by BHS.
No documented statistics prove the statement of the authors, 5 that 'the differences between the two methods were not related to the level of blood pressure'. We could discriminate 382 out of 407 values from the published BLAND and ALTMAN plot yielding the following significant regression (P Ͻ 0.001) line for the diastolic differences:
Consequently, 18.9 mm Hg decrease of diastolic blood pressure would have been measured by the Korotkoff method compared to 22.3 mm Hg stated in the HOT study, and an 84.6 mm Hg diastolic trough point for risk of major cardiovascular events, when measured by the standard method, compares to the study's 82.6 mm Hg. Additionally we found ±12.5 mm Hg when looking for the 95% CI at 82 mm Hg which agrees with the statistics expressed in another form by the authors (see below).
In the published test four different specimens of Visomat gave average systolic differences ranging from −4.6 to −7.4 mm Hg, and diastolic differences ranging from −3.1 to +1.4 mm Hg. Comparative test statistics are lacking in the paper.
Caution is suggested in taking 82.6 mm Hg (diastolic) and 138.5 mm Hg (systolic) as the new general target pressures in the treatment of hypertension, considering the documented inaccuracy of blood pressure measurement in the HOT study. According to the published descriptive statistics, in every third patient a mean diastolic pressure of 82 mm Hg (average of four Visomat measurements) may correspond to р77 mm Hg or у87 mm Hg taken by the Korotkoff method. Additionally, six out of 10 patients with a systolic Visomat pressure of 138 mm Hg will have Korotkoff values lower than 133 mm Hg or higher than 143 mm Hg, with most being higher.
In the HOT study the inaccuracy of the device used may also explain the very shallow J-curve of the graph correlating risk to measured blood pressure.
From the facts cited at the beginning of this letter, and from the given example, some rules for the application of automatic instruments for the measurement of blood pressure in controlled clinical trials may be derived.
(1) Substitution of the standard Korotkoff method by automatic devices in clinical trials must be well-founded. The principle of automated measurement-Korotkoff sounds, oscillometry, ultrasound and othersmakes no difference.
(2) The applied instruments must be tested before starting the trial, followed by continuous surveillance of all instruments used during the trial.
(3) When testing the automatic devices, the relevant characteristics of the patients included in the trial, such as their age [6] [7] [8] and range of blood pressure, 9 must be representative. (4) The consequences of the test results for the conclusions of the clinical trial must be discussed in its final publication. This point is extremely important when looking for new target values for antihypertensive treatment, but also relevant in comparative drug studies.
Up to now, the non-automated
Reply to the letter from M Anlauf, U Tholl, H Hirche and F Weber
We are surprised that Prof Anlauf and colleagues 1 have commented on the blood pressure measurement method in the HOT Study 2 such a long time after the results of the study were published. We find it even more astonishing, as their comments are mainly irrelevant.
We used the average of four readings for the comparison between the methods. This is closer to the clinical situation than a single reading. In comparison with the situation in the HOT Study 2 where three readings were routinely used our results indicate good agreement between the methods. These results are in line with the BHS 3 criteria except for difference in systolic blood pressmethod of indirect blood pressure measurement as developed by Riva-Rocci and Korotkoff remains the golden standard which yielded nearly all insights into the problem of hypertension and its management. At this time, a new standard of automated blood pressure measurement has not been created, so we can make use of the indisputable advantages of automation without risk only by sticking to well defined protocols for continuous comparisons. ure where the average value is 6.4 mm Hg (BHS 5 mm Hg) and the proportion of absolute differences less than 5 mm Hg is 40% compared to the BHS value of 50%. In all other cases the results agree well with the BHS criteria and for diastolic blood pressure (the target variable in the HOT Study) the mean difference between methods is 0.9 mm Hg where BHS permits 5 mm Hg.
The weak relation between difference and average diastolic value noted by Anlauf et al 1 has small clinical significance. In the medium pressure range 80-100 mm Hg (which BHS recommends for sub-analysis of data and which also is the important target range for the HOT Study) the mean dif-ference is 0.9 mm Hg and not 2.2 mm Hg as Anlauf et al claim.
It must be pointed out that the reason for plotting the difference vs the average value (Oldham's method 4 ) and not vs eg the value from the sphygmomanometer, is to avoid a spurious correlation that otherwise would emerge due to the measurement error in the xvariable. Although this method normally gives satisfactory unbiased result it can give a small spurious correlation when the two methods have different measurement errors. 5 In the case with diastolic blood pressure the Visomat method have slightly higher intra-individual variation and this is probably the cause for the weak relation between difference and average value.
